Education Comments Synapses Suffer When Splicing Goes Awry in TDP-43 Proteinopathy 03 Jun 2026 ...
Alzheimerologists, it is time to update your GWAS catalogue—again. In June 3 Nature Genetics, a staggering 508 scientists (yes, we counted) from across the United States and Europe, led by Céline ...
Associate Professor Buck Institute for Research on Aging https://www.buckinstitute.org/lab/tracy-lab/ ...
Early dopamine disruption in the entorhinal cortex of a knock-in model of Alzheimer's disease. 02 Jun 2026 ...
Professional Information Research FellowMonash University Brain Waste, Please Proceed to Your Nearest Exit 29 May 2026 ...
Jae-Sung Lim, Ph.D. University of Ulsan College of Medicine Contact Information Jae-Sung Lim, Ph.D. Seoul, Korea, Republic of ...
A blood test may be almost as good as a brain scan for determining where someone lies along the Alzheimer’s disease continuum. So conclude scientists led by Gemma Salvadó and Oskar Hansson at Lund ...
Low dose interleukin 2 is being tested as an immunomodulatory approach in neurodegenerative diseases. It increases the number and activity of regulatory T cells (Tregs) that suppress inflammation. At ...
Professional Information Graduate Student in Mathematics and NeurosurgeonMississippi State University Education BS biochemistry Tulane MD Tulane ...
Department of Geriatric Medicine Karolinska University Hospital Huddinge 141 86Stockholm Sweden Visit Website Contact: Professor Agneta Nordberg, Professor Lars-Olof Wahlund, Caroline Graff, Professor ...
This database is a repository of normal genetic variability, designed to be a tool for researchers who study neurodegenerative disease. It contains whole-exome sequencing results from nearly 500 ...
Score another one for amyloid immunotherapy. The anti-pyroglutamated amyloid antibody donanemab has posted positive top-line results in the Phase 3 Trailblazer-Alz2 study, according to an Eli Lilly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results